Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
78 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-18 |
Cash Flow (TTM) (Millions $) |
21 |
Capital Exp. (TTM) (Millions $) |
2 |
Chelsea Therapeutics International, Ltd.
Chelsea Therapeutics International, Ltd. is a pharmaceutical company that focuses on the development and commercialization of innovative therapeutics for rare diseases. Based in the United States, Chelsea Therapeutics is dedicated to addressing unmet medical needs through its research and development efforts. The company aims to bring novel treatment options to patients who are currently underserved by existing therapies. Chelsea Therapeutics has expertise in multiple therapeutic areas, including neurology, immunology, and genetic disorders. They strive to improve the lives of patients and make a positive impact on healthcare.
|